The Deal
Sunday, November 8, 
2:39 pm

Deal Stocks mixed as Dow rebounds from midday sell-off

  Share     E-Mail    Discussion    Print Story
While the Dow Jones Industrial Average finished down 45.10 points to 12,213.80, its fourth consecutive session decline, the market could have faired much worse for the day, having tumbled nearly 150 points in midday trading Tuesday. Deal Stocks rode the Dow's ebb and flow and ultimately had a mixed finish.

Continue reading below

Also on Dealscape

The Dow's midday sell-off was prompted by a combination of lowered earnings projections on Citigroup Inc. and a pessimistic view on future home foreclosures by Fed Chairman Ben Bernanke. A late-day rebound may have been driven by investors buying on the cheap as well as reports that bond insurer Ambac Financial Group Inc. is closer to a recapitalization deal. 
 
  • Ethanol producer U.S. Bionergy Corp., which is weeks away from the expected close of its roughly $700 million sale to VeraSun Energy Corp., spiraled downward 13.43% to $6.19 per share. Ethanol stocks crashed as investors sold off amid fear that record high corn prices will put the squeeze on these companies' bottom lines.
  • IPass Inc.'s stock reacted negatively to activist shareholder Shamrock Activist Value Fund's push for a sale, as the stock slid 4.29% to $2.68 per share. Shamrock in a statement issued late Monday demanded that the technology company consider a sale.
  • Spectrum Brands Inc. fell on the positive side of the mixed bag, climbing 3.37% to $3.99 per share. Spectrum over the past year and a half has announced plans to sell its home and garden business and pet products business, which has yet to come to fruition due in part to the credit crunch and recent tough season for the lawn and garden sector. Harbinger Capital Partners Master Fund I Ltd. filed a 13D with the Securities and Exchange Commission announcing that it had entered into a confidentiality agreement with Spectrum to evaluate a possible transaction.
- Michael Rudnick




Post a comment





The Deal Pipeline

Deal Video


Inside The Deal: Linklaters' Schmidt says how regulators handled Pfizer Inc.'s acquisition of Wyeth is an outlier of how others merger reviews will be conducted.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Dealing with frozen bank lending

If your bank is not willing to lend, what can you do as your company continues to seek growth?


Judgment Call

The coming age of the renminbi

The Chinese currency will play an increasingly important role in international commerce and finance.


Industry Insight

Banking on PE investments

Howls of protest greeted the FDIC policy statement, but the financial services industry should get over it.


footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.